1.No Title.
Do Young CHUNG ; Young Soo KIM
Journal of the Korean Continence Society 1997;1(1):53-53
No abstract available.
3.Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy.
Tejune CHUNG ; Won Sang CHUNG ; Young Hak KIM
Journal of the Korean Cancer Association 1991;23(2):424-428
No abstract available.
Drug Therapy*
4.Effects of glutamate and glycine on the binding of 3HMK-801 to the N-Methyl-K-Aspartate receptor in rat brain.
Young In CHUNG ; Young Hoon KIM ; Myung Jung KIM
Journal of Korean Neuropsychiatric Association 1993;32(4):545-553
No abstract available.
Animals
;
Brain*
;
Glutamic Acid*
;
Glycine*
;
Rats*
5.A clinical analysis of 72 renal transplantations.
Sang Young CHUNG ; Shin Kon KIM
The Journal of the Korean Society for Transplantation 1991;5(1):17-26
No abstract available.
Kidney Transplantation*
6.A clinical analysis of 72 renal transplantations.
Sang Young CHUNG ; Shin Kon KIM
The Journal of the Korean Society for Transplantation 1991;5(1):17-26
No abstract available.
Kidney Transplantation*
7.A clinical review of early gastric cancer.
Journal of the Korean Surgical Society 1992;43(3):321-329
No abstract available.
Stomach Neoplasms*
8.Detection of genital herpes infection by culturing herpes simplex virus and immunofluorecent stain.
Korean Journal of Obstetrics and Gynecology 1992;35(9):1324-1336
No abstract available.
Herpes Genitalis*
;
Herpes Simplex*
;
Simplexvirus*
9.Portal hypertension in children.
Journal of the Korean Pediatric Society 1992;35(11):1528-1536
No abstract available.
Child*
;
Humans
;
Hypertension, Portal*
10.Predominant Th2 type immune response in bronchoalveolar lavage fluid of patients with Mycoplasma pneumoniae pneumonia.
Chang Keun KIM ; Churl Young CHUNG
Journal of Asthma, Allergy and Clinical Immunology 1999;19(5):647-655
OBJECTIVE: Mycoplasma pneumoniae infection is known as one of the frequent causes of exacerbation of bronchial asthma and it can also be a trigger for the initiation of asthma. However, little is known about the pathogenesis of respiratory M. pneumoniae infection. Furthermore, there is little data on human cytokine production and its involvement in the pathogenesis of M. pneumoniae infection. In order to investigate the immunopathogenesis of M. pneumoniae infection, we investigated the cytokine production in the bronchoalveolar lavage ( BAL ) fluid of patients with M. pneumoniae pneumonia and viral pneumonia, and compared the results with those of control subjects. SUBJECT AND METHOD: BAL was performed with fiberoptic bronchoscopy in patients with M. pneumoniae pneumonia( n=9 ), viral pneumonia( n=9 ), and control subjects( n=6 ) aged 3 years to 9 years. M. pneumoniae pneumonia was documented by polymerase chain reaction and serologic analysis. Four respiratory viruses ( adenovirus, influenza A, influenza B, parainfluenza ) were detected by culture method. Cell pellets and supernatants were separated by centrifugation and Interleukin( IL ) - 2, Interferon( IFN )-r, IL-4, and IL-5 levels were measured in concentrated BAL supernatants by ELISA. RESULTS: Analysis of cytokines revealed significantly increased production of IL-4 ( p< 0.0001 ) and IL-2 ( p< 0.0001 ), in patients with M. pneumoniae pneumonia and significantly increased production of IL-2 (p <0.0001) in patients with viral pneumonia compared with those of the control subjects. Ratio of IL-4/IFN-r was significantly increased in patients with M. pneumoniae pneumonia ( p< 0.005 ) but not in patients with viral pneumonia compared with that of the control subjects. CONCLUSION: IL-4 production and IL-4/IFN-r ratio were increased in the BAL fluid of patients with M. pneumoniae infection. These findings suggest that predominant Th2 immune response could play an important role in the pathogenesis of M. pneumoniae infection.
Adenoviridae
;
Asthma
;
Bronchoalveolar Lavage Fluid*
;
Bronchoalveolar Lavage*
;
Bronchoscopy
;
Centrifugation
;
Cytokines
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Influenza, Human
;
Interleukin-2
;
Interleukin-4
;
Interleukin-5
;
Mycoplasma pneumoniae*
;
Mycoplasma*
;
Paramyxoviridae Infections
;
Pneumonia*
;
Pneumonia, Mycoplasma*
;
Pneumonia, Viral
;
Polymerase Chain Reaction